HSBC Holdings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
HSBC Holdings's ELV Position: Q1 2026 in Review
HSBC Holdings increased its Elevance Health (ELV) stake by 0.9% in Q1 2026, buying an estimated $1.5M and bringing the position to 511,067 shares worth $150M. The position accounts for 0.08% of the portfolio, ranked #244.
HSBC Holdings first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- HSBC Holdings held 511,067 shares of Elevance Health worth $150M as of Q1 2026.
- HSBC Holdings bought 4,563 Elevance Health shares in Q1 2026, an estimated $1.5M.
- Elevance Health made up 0.08% of HSBC Holdings's portfolio in Q1 2026, its #244 holding.
- HSBC Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Elevance Health position peaked at $480M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.